China
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
17.23%
|
Dec. 31, 2023 | USD 0.32 | 1.60% |
|
China |
|
2 |
9.62%
|
Dec. 31, 2023 | USD 0.16 | 1.63% |
|
China |
|
3 |
3.90%
|
Dec. 31, 2023 | USD 0.15 | 14.99% |
|
China |
|
4 |
-0.28%
|
Dec. 31, 2023 | USD 7.99 | -2.56% |
|
China |
|
5 |
-0.45%
|
Dec. 31, 2023 | USD 39.90 | -5.43% |
|
China |
|
6 |
-1.45%
|
Dec. 31, 2023 | USD 2.31 | -2.94% |
|
China |
|
7 |
-47.89%
|
Dec. 31, 2023 | USD 0.21 | 6.61% |
|
China |
|
8 |
-89.22%
|
Dec. 31, 2023 | USD 1.90 | 2.70% |
|
China |
The Venture Capital company in China with the highest EBIT Margin is Jinxin Fertility Group Limited (HKSE: 1951.HK) at 17.23%.
The Venture Capital company in China with the lowest EBIT Margin is Adagene Inc. (NasdaqGM: ADAG) at -89.22%.
The top 10 Venture Capital companies in China by EBIT Margin are Jinxin Fertility Group Limited, Zero2IPO Holdings Inc., Ziyuanyuan Holdings Group Limited, X Financial, Qifu Technology, Inc., Lufax Holding Ltd, Linklogis Inc. and Adagene Inc..
The bottom 10 Venture Capital companies in China by EBIT Margin are Adagene Inc., Linklogis Inc., Lufax Holding Ltd, Qifu Technology, Inc., X Financial, Ziyuanyuan Holdings Group Limited, Zero2IPO Holdings Inc. and Jinxin Fertility Group Limited.